No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Stocks in Play: Crescita Therapeutics Inc.
Crescita Therapeutics Introduces "World's Smallest Intradermal Delivery Device"
Crescita Therapeutics Announces the Results of Its Annual General and Special Meeting of Shareholders
Crescita Therapeutics Q1 Loss Widens, Revenue Rises
Crescita Therapeutics Brief: Q1 Revenue Was $4.996 Million
Crescita Reports Third Quarter 2023 Results